Current guideline recommendations for the use of beta-blockers after myocardial infarction without reduced ejection fraction are based on trials conducted before routine reperfusion, invasive care, ...

In patients with heart failure with preserved ejection fraction (HFpEF) and chronotropic incompetence, indexed left ventricular systolic volume (iLVESV) may predict those who could benefit most from ...

Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ...

Ejection fraction (EF) measures how well the heart pumps blood. A normal ejection fraction is between 55% to 70%. A low ejection fraction can be a sign of heart failure. Ejection fraction (EF) ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Among patients with heart failure with preserved ejection fraction (HFpEF) who have chronotropic incompetence, those with lower left ventricular systolic volume might benefit from discontinuing beta ...

AstraZeneca’s SGLT2 diabetes drug Forxiga has another approval to celebrate. The drug, known as Farxiga in the U.S., gained a nod in Europe to treat patients suffering from heart failure with any type ...

Is your heart functioning properly? There is a test which can measure this, which is often recommended by medical ...